Search Results - salvatore+oddo

2 Results Sort By:
New Strategies to Block RIPK1/3/MLKL-Mediated Neurodegeneration
University of Arizona researchers have discovered several small molecules that represent a new class of RIPK1/3 targeting therapeutics that can potentially be used in the treatment of Alzheimer’s Disease. These molecules inhibit necroptosis, which is a cell death pathway related to neurodegenerative diseases. Necroptosis is form of cell death...
Published: 4/3/2023   |   Inventor(s): May Khanna, Jonathan Sanchez, Vijay Gokhale, Salvatore Oddo
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Neurology, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Small Molecules
Gene Transfer to Improve Cognitive Dysfunction in Alzheimer’s Disease
University of Texas Health Science Center at San Antonio researchers have developed a unique therapeutic approach which could restore learning and memory ability in those afflicted with Alzheimer’s Disease and other neurodegenerative diseases. Abnormalities in the expression of cAMP-response element binding protein (CREB) have been reported in...
Published: 1/16/2019   |   Inventor(s): Salvatore Oddo, Antonella Caccamo
Keywords(s):  
Category(s): Clinical Specialty > Neurology, Therapeutics > Small Molecule